StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — ICICI Securities

BUYGlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)6 Nov 2026via Institutional / Brokerage Research

Entry₹2,524.8Inferred
Target₹2,900
Total upside +14.86%
Stop lossNot given
CMP₹2,672.61d ago
Active+5.85%+8.51%upside left 12 mo left
Follow ICICI Securities for new calls(62% target hit, 1145 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alertsSee 1 other Long-term call on GLAXOSee 273 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:36 am IST
16 supporting2 neutral0 opposing
Supports the BUY call (16)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·13 Nov · yesterday

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·11 Nov · 3d ago

GSK Pharma Q2FY27 profit up 31% to ₹334.6 crore; underlying growth 12-13%

NewsGoogle News·8 Nov · 6d ago

(opens in new tab)

GlaxoSmithKline Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

NewsGoogle News·7 Nov · 1w ago

(opens in new tab)

GSK India: chronic therapies outpaced acute drugs in Q2 FY27

NewsGoogle News·5 Nov · 1w ago

(opens in new tab)
Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on GlaxoSmithKline Pharmaceuticals

All analyst calls on GlaxoSmithKline Pharmaceuticals

More from ICICI Securities

Every call and its outcome